Refine
Has Fulltext
- yes (358)
Year of publication
- 2018 (358) (remove)
Document Type
- Journal article (358) (remove)
Keywords
- Parton Distributions (23)
- Hadron-Hadron scattering (experiments) (16)
- Extension (14)
- Decay (13)
- Positronen-Emissions-Tomografie (12)
- Squark (11)
- ++ (10)
- PET (10)
- positron emission tomography (8)
- Mass (7)
Institute
- Physikalisches Institut (71)
- Theodor-Boveri-Institut für Biowissenschaften (52)
- Klinik und Poliklinik für Nuklearmedizin (26)
- Medizinische Klinik und Poliklinik II (15)
- Institut für Psychologie (14)
- Institut für Virologie und Immunbiologie (14)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (14)
- Medizinische Klinik und Poliklinik I (14)
- Institut für Sportwissenschaft (9)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (9)
- Institut für Anatomie und Zellbiologie (8)
- Institut für Geographie und Geologie (8)
- Institut für Humangenetik (8)
- Julius-von-Sachs-Institut für Biowissenschaften (8)
- Kinderklinik und Poliklinik (7)
- Pathologisches Institut (7)
- Institut für Pharmakologie und Toxikologie (6)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (6)
- Lehrstuhl für Orthopädie (6)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (6)
- Neuphilologisches Institut - Moderne Fremdsprachen (6)
- Neurologische Klinik und Poliklinik (6)
- Institut für Anorganische Chemie (5)
- Institut für Hygiene und Mikrobiologie (5)
- Institut für Molekulare Infektionsbiologie (5)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (5)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (5)
- Center for Computational and Theoretical Biology (4)
- Institut für Funktionsmaterialien und Biofabrikation (4)
- Institut für Informatik (4)
- Institut für Theoretische Physik und Astrophysik (4)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (4)
- Rudolf-Virchow-Zentrum (4)
- Augenklinik und Poliklinik (3)
- Institut Mensch - Computer - Medien (3)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Institut für Pharmazie und Lebensmittelchemie (3)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (3)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (3)
- Lehrstuhl für Molekulare Psychiatrie (3)
- Physiologisches Institut (3)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (2)
- Comprehensive Cancer Center Mainfranken (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (2)
- Frauenklinik und Poliklinik (2)
- Institut für Klinische Neurobiologie (2)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (2)
- Institut für Mathematik (2)
- Institut für Medizinische Strahlenkunde und Zellforschung (2)
- Institut für Physikalische und Theoretische Chemie (2)
- Institut für Politikwissenschaft und Soziologie (2)
- Institut für deutsche Philologie (2)
- Institut für klassische Philologie (2)
- Klinik und Poliklinik für Strahlentherapie (2)
- Betriebswirtschaftliches Institut (1)
- Fakultät für Physik und Astronomie (1)
- Graduate School of Life Sciences (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Organische Chemie (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
- Katholisch-Theologische Fakultät (1)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (1)
- Medizinische Fakultät (1)
- Poliklinik für Kieferorthopädie (1)
- Universitätsbibliothek (1)
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (10)
- Johns Hopkins University School of Medicine (4)
- Department of Biomedical Imaging, National Cerebral and Cardiovascular Research Center, Suita, Japan (1)
- Department of Nuclear Medicine, Kanazawa University (1)
- Division of Medical Technology and Science, Department of Medical Physics and Engineering, Course of Health Science, Osaka University Graduate School of Medicine, Suita Japan (1)
- Institut for Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Leopold-Franzens-University Innsbruck, Innsbruck, Austria (1)
- Johns Hopkins Medicine (1)
- Johns Hopkins School of Medicine, Baltimore, MD, USA (1)
- Johns Hopkins School of Medicine, The Russell H Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA (1)
- Johns Hopkins University, Baltimore, MD, U.S. (1)
In der vorliegenden Arbeit wird ein neues Teilareal von T. micranthum mit zahlreichen Vorkommen an den Nordseedeichen von Schleswig-Holstein zwischen der Elbeästuar und der Insel Nordstrand mit Schwerpunkt auf der Halbinsel Eiderstedt mitgeteilt, das geographisch zwischen dem Vorkommen in den Niederlanden und dem Ostsee-Areal in Dänemark vermittelt. Es handelt sich um die einzigen weitgehend naturnahen Wuchsorte der Art in Deutschland. Die anderen beiden aktuellen deutschen Vorkommen befinden sich auf Friedhöfen in Nordrhein-Westfalen. T. micranthum wächst bevorzugt an den steilen und artenreicheren Innenböschungen der Seedeiche, deren Vegetation durch intensive Schafbeweidung und Trittspuren kurz und lückig gehalten wird. Die Beweidung bewirkt eine signifikante Größenreduktion (Miniaturisierung) verschiedener Pflanzenteile. Widersprüchliche Angaben zu bestimmungskritischen Merkmalen werden durch morphometrische Untersuchungen überprüft. Unter anderem beträgt die Länge der Blütenstiele 0,6–1,1 mm (im Mittel 0,8 mm) und die Blüten mit Kelch sind deutlich unter 3 mm lang (im Mittel 2,4 mm). Die Zahl der Blüten der Infloreszenz beträgt (1)2–6(8). Eine graphische Darstellung soll bei Artbestimmung und Auffinden neuer Wuchsorte behilflich sein.
Rubus pseudoglotta Drenckhahn & W. Jansen ist eine tetraploide Brombeerart aus der Sektion Corylifolii (Serie Subradula), die bisher zum Variabilitäts-Spektrum von R. phylloglotta (Frid.) Å. Gust. gezählt wurde. Charakteristische Merkmale sind die 4 (3–5)-zähligen Blätter mit obovaten Endblättchen mit kurzer (ca. 1 cm) abgesetzter Spitze, kurzhaariger Blattoberseite und fühlbar behaarter grüner Blattunterseite. Die flach bogigen, teils klimmenden Schösslinge sind überwiegend stumpfkantig, grün bis rötlichbraun, schwach behaart und reichlich mit 2–4 (5) mm langen, geraden bis schwach gekrümmten Stacheln und kleineren Stacheln, Stachelhöckern, Stieldrüsen und Borsten besetzt. Die Blütenstiele sind mit 2–8 (pro cm) schlanken, geraden bis leicht gekrümmten Stacheln (1–2 mm lang) und zahlreichen Stieldrüsen (teils bis 0,6 mm lang) besetzt. Die Sippe wächst bevorzugt an Straßen- und Wegrändern und in Hecken. Die bekannt gewordenen Fundstellen erstrecken sich von Rendsburg bis in das Umfeld von Kiel, nordwärts bis zu den dänischen Inseln Alsen und Fünen. Unsere Untersuchungen zeigen weiterhin, dass R. phylloglotta bisher nicht in Schleswig-Holstein/Deutschland nachgewiesen wurde. Ob R. phylloglotta überhaupt außerhalb der Insel Tåsinge in Dänemark vorkommt, bedarf weiterer Nachforschungen.
Background:
The cardiac hormones atrial (ANP) and B-type natriuretic peptides (BNP) moderate arterial blood pressure and improve energy metabolism as well as insulin sensitivity via their shared cGMP-producing guanylyl cyclase-A (GC-A) receptor. Obesity is associated with impaired NP/GC-A/cGMP signaling, which possibly contributes to the development of type 2 diabetes and its cardiometabolic complications. In vitro, synthetic ANP, via GC-A, stimulates glucose-dependent insulin release from cultured pancreatic islets and β-cell proliferation. However, the relevance for systemic glucose homeostasis in vivo is not known. To dissect whether the endogenous cardiac hormones modulate the secretory function and/or proliferation of β-cells under (patho)physiological conditions in vivo, here we generated a novel genetic mouse model with selective disruption of the GC-A receptor in β-cells.
Methods:
Mice with a floxed GC-A gene were bred to Rip-CreTG mice, thereby deleting GC-A selectively in β-cells (β GC-A KO). Weight gain, glucose tolerance, insulin sensitivity, and glucose-stimulated insulin secretion were monitored in normal diet (ND)- and high-fat diet (HFD)-fed mice. β-cell size and number were measured by immunofluorescence-based islet morphometry.
Results:
In vitro, the insulinotropic and proliferative actions of ANP were abolished in islets isolated from β GC-A KO mice. Concordantly, in vivo, infusion of BNP mildly enhanced baseline plasma insulin levels and glucose-induced insulin secretion in control mice. This effect of exogenous BNP was abolished in β GC-A KO mice, corroborating the efficient inactivation of the GC-A receptor in β-cells. Despite this under physiological, ND conditions, fasted and fed insulin levels, glucose-induced insulin secretion, glucose tolerance and β-cell morphology were similar in β GC-A KO mice and control littermates. However, HFD-fed β GC-A KO animals had accelerated glucose intolerance and diminished adaptative β-cell proliferation.
Conclusions:
Our studies of β GC-A KO mice demonstrate that the cardiac hormones ANP and BNP do not modulate β-cell's growth and secretory functions under physiological, normal dietary conditions. However, endogenous NP/GC-A signaling improves the initial adaptative response of β-cells to HFD-induced obesity. Impaired β-cell NP/GC-A signaling in obese individuals might contribute to the development of type 2 diabetes.
Renin–angiotensin system (RAS) plays an important role in the regulation of blood pressure and hormonal balance. Using positron emission tomography (PET) technology, it is possible to monitor the physiological and pathological distribution of angiotensin II type 1 receptors (AT\(_1\)), which reflects the functionality of RAS. A new \(^{18}\)F-labeled PET tracer derived from the clinically used AT\(_1\) antagonist valsartan showing the least possible chemical alteration from the valsartan structure has been designed and synthesized with several strategies, which can be applied for the syntheses of further derivatives. Radioligand binding study showed that the cold reference FV45 (K\(_i\) 14.6 nM) has almost equivalent binding affinity as its lead valsartan (K\(_i\) 11.8 nM) and angiotensin II (K\(_i\) 1.7 nM). Successful radiolabeling of FV45 in a one-pot radiofluorination followed by the deprotection procedure with 21.8 ± 8.5% radiochemical yield and >99% radiochemical purity (n = 5) enabled a distribution study in rats and opened a path to straightforward large-scale production. A fast and clear kidney uptake could be observed, and this renal uptake could be selectively blocked by pretreatment with AT\(_1\)-selective antagonist valsartan. Overall, as the first \(^{18}\)F-labeled PET tracer based on a derivation from clinically used drug valsartan with almost identical chemical structure, [\(^{18}\)F]FV45 will be a new tool for assessing the RAS function by visualizing AT\(_i\) receptor distributions and providing further information regarding cardiovascular system malfunction as well as possible applications in inflammation research and cancer diagnosis.
As a scintigraphic approach evaluating cardiac nerve integrity, \(^{123}\)I-metaiodobenzylguanidine (123I-mIBG) has been recently Food and Drug Administration approved. A great deal of progress has been made by the prospective ADMIRE-HF trial, which primarily demonstrated the association of denervated myocardium assessed by \(^{123}\)I-mIBG and cardiac events. However, apart from risk stratification, myocardial nerve function evaluated by molecular imaging should also be expanded to other clinical contexts, in particular to guide the referring cardiologist in selecting appropriate candidates for specific therapeutic interventions. In the present issue of the Journal of Nuclear Cardiology, the use of 123I-mIBG for identifying cardiomyopathy patients, which would most likely not benefit from ICD due low risk of arrhythmias, is described. If we aim to deliver on the promise of cardiac innervation imaging as a powerful tool for risk stratification in a manner similar to nuclear oncology, studies such as the one reviewed here may imply an important step to lay the proper groundwork for a more widespread adoption in clinical practice.
Purpose:
The prescribing of oral chemotherapy agents has introduced the new challenge of ensuring patients’ adherence to therapy. Aspects of a close patient–doctor relationship are reported to be correlated with adherence to oral anticancer drugs, but data on capecitabine are scarce.
Patients and methods:
Sixty-four outpatients with a diagnosis of cancer and prescribed capecitabine were recruited from a German Comprehensive Cancer Center. We used the Patient–Doctor Relationship Questionnaire (PDRQ-9), the Medical Adherence Rating Scale (MARS), the Beliefs about Medicines Questionnaire (BMQ), and the Satisfaction with Information about Medicines Scale (SIMS) to assess patients’ perceptions and behavior. Medical data were extracted from the charts.
Results:
Non-adherence was reported by 20% of the 64 participants. The perceived quality of the patient–doctor relationship was high in general, but it did not emerge as a predictor of adherence in our survey (odds ratio [OR]=0.915, P=0.162, 95% CI=0.808–1.036). However, beliefs about medicine (OR=1.268, P<0.002; 95% CI=1.090–1.475) as well as satisfaction with information about medicine (OR=1.252, P<0.040, 95% CI=1.010–1.551) were predictors of adherence and the quality of the patient–doctor relationship was correlated with both variables (r=0.373, P=0.002 for SIMS sum score; r=0.263, P=0.036 for BMQ necessity/concern difference). Overall, adherence to capecitabine was high with a conviction that the therapy is necessary. However, concerns were expressed regarding the long-term effect of capecitabine use. Patients have unmet information needs regarding interactions of capecitabine with other medicines and the impairment of their intimate life.
Conclusions:
In order to ensure adherence to capecitabine, our results seem to encourage the default use of modern and perhaps more impersonal means of information brokerage (eg, email, internet). However, the contents of some of patients’ informational needs as well as the associations of patients’ beliefs and satisfaction about the information received suggest a benefit from a trustful patient–doctor relationship.
This paper proposes a 3-D local pose estimation system for a small Unmanned Aerial Vehicle (UAV) with a weight limit of 200 g and a very small footprint of 10 cm×10cm. The system is realized by fusing 3-D position estimations from an Ultra-Wide Band (UWB) transceiver network with Inertial Measurement Unit (IMU) sensor data and data from a barometric pressure sensor. The 3-D position from the UWB network is estimated using Multi-Dimensional Scaling (MDS) and range measurements between the transceivers. The range measurements are obtained using Double-Sided Two-Way Ranging (DS-TWR), thus eliminating the need for an additional clock synchronization mechanism. The sensor fusion is accomplished using a loosely coupled Extended Kalman Filter (EKF) architecture. Extensive evaluation of the proposed system shows that a position accuracy with a Root-Mean-Square Error (RMSE) of 0.20cm can be obtained. The orientation angle can be estimated with an RMSE of 1.93°.
Background:
ATF5 suppresses differentiation of neuroprogenitor cells and is overexpressed in glioblastoma (GBM). A reduction of its expression leads to apoptotic GBM cell death. Data on ATF5 expression in astrocytoma WHO grade II (low-grade astrocytoma [LGA]) are scarce and lacking on recurrent GBM.
Patients and methods:
ATF5 mRNA was extracted from frozen samples of patients’ GBM (n=79), LGA (n=40), and normal brain (NB, n=10), quantified by duplex qPCR and correlated with retrospectively collected clinical data. ATF5 protein expression was evaluated by measuring staining intensity on immunohistochemistry.
Results:
ATF5 mRNA was overexpressed in LGA (sevenfold, P<0.001) and GBM (tenfold, P<0.001) compared to NB, which was confirmed on protein level. Although ATF5 mRNA expression in GBM showed a considerable fluctuation range, groups of varying biological behavior, that is, local/multifocal growth or primary tumor/relapse and the tumor localization at diagnosis, were not significantly different. ATF5 mRNA correlated with the patients’ age (r=0.339, P=0.028) and inversely with Ki67-staining (r=-0.421, P=0.007). GBM patients were allocated to a low and a high ATF5 expression group by the median ATF5 overexpression compared to NB. Kaplan–Meier analysis and Cox regression indicated that ATF5 mRNA expression significantly correlated with short-term survival (t<12 months, median survival 18 vs 13 months, P=0.022, HR 2.827) and progression-free survival (PFS) (12 vs 6 months, P=0.024). This advantage vanished after 24 months (P=0.084).
Conclusion:
ATF5 mRNA expression could be identified as an additional, though not independent factor correlating with overall survival and PFS. Since its inhibition might lead to the selective death of glioma cells, it might serve as a potential ubiquitous therapeutic target in astrocytic tumors.
A new twelvefold methoxy-triethyleneglycol-jacketed tetraphenoxy-perylene bisimide (MEG-PBI) amphiphile was synthesized that self-assembles into two types of supramolecular aggregates in water: red-coloured aggregates of low order and with weak exciton coupling among the PBIs and blue-coloured strongly coupled J-aggregates consisting of a highly ordered hydrogen-bonded triple helix of PBIs. At room temperature this PBI is miscible with water at any proportions which enables the development of robust dye aggregates in solution, in hydrogel states and in lyotropic liquid crystalline states. In the presence of 60–95 wt% water, self-standing coloured hydrogels exhibit colour changes from red to blue accompanied by a fluorescence light-up in the far-red region upon heating in the range of 30–50 °C. This phenomenon is triggered by an entropically driven temperature-induced hydrogen-bond-directed slipped stacking arrangement of the MEG-PBI chromophores within structurally well-defined J-aggregates. This versatile aqua material is the first example of a stable PBI J-aggregate in water. We anticipate that this study will open a new avenue for the development of biocompatible functional materials based on self-assembled dyes and inspire the construction of other hydrogen-bonded supramolecular materials in the highly competitive solvent water.